News
15h
Zacks Investment Research on MSNNVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 TrialNovocure NVCR recently announced positive top-line results from its pivotal Phase 3 PANOVA-3 trial, evaluating Tumor Treating ...
The documents were released ahead of the 81st anniversary of D-Day, the Allied invasion of Normandy on June 6, 1944 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results